Hot Features
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac diseas... Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.36 | -7.48074807481 | 18.18 | 18.59 | 15.51 | 333578 | 16.6332583 | CS |
| 4 | -7.54 | -30.9523809524 | 24.36 | 25.01 | 15.51 | 255688 | 19.2763546 | CS |
| 12 | -9.29 | -35.5802374569 | 26.11 | 35.7999 | 15.51 | 307785 | 26.69175082 | CS |
| 26 | -3.15 | -15.7736604907 | 19.97 | 35.7999 | 15.51 | 255622 | 27.69550151 | CS |
| 52 | 4.87 | 40.7531380753 | 11.95 | 35.7999 | 9.1 | 177526 | 23.51854354 | CS |
| 156 | 15.81 | 1565.34653465 | 1.01 | 35.7999 | 0.2796 | 132182 | 16.00077842 | CS |
| 260 | -23.69 | -58.4793878055 | 40.51 | 42.69 | 0.2796 | 253868 | 9.31953435 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.